Jeannie Callum, University of Ottawa

Research

Acute Kidney Injury Critical Illness Dialysis Hemodynamic Instability Related To Renal Replacement Therapy Intradialytic Hypotension Intravenous Albumin Multicentre Randomized Controlled Trial Renal Replacement Therapy

Latest papers

Quality of life and cost‐effectiveness of convalescent plasma compared to standard care for hospitalized COVID‐19 patients in the CONCOR‐1 trial
Transfusion · 2024
Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Nature Medicine · 2022
Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19
Nature Medicine · 2022

All 6 publications

Latest funding

The ICONIC trial: Intraoperative Cell salvage to Optimize allogeNeic transfusion In liver Cancer surgery
CIHR · 2026 · Co-investigator
$1,640,542
The TOPGUN trial: Threshold for OPerative hemoGlobin trigger for red blood cell transfUsioN
CIHR · 2026 · Co-investigator
$4,039,200
Small-Volume Tubes to Reduce Anemia and Transfusion Expansion Phase (STRATUS-X) Trial Planning Grant
CIHR · 2025 · Co-investigator
$20,000

All 4 grants and awards

6 publications.

01

Quality of life and cost‐effectiveness of convalescent plasma compared to standard care for hospitalized COVID‐19 patients in the CONCOR‐1 trial

Tse P, Yan J, Liu Y, Jamula E, Heddle N, Bazin R, Robitaille N, Cook R, Turgeon A, Fergusson D

Transfusion20244 citationsOpen Access

DOI: 10.1111/trf.17777 PMID: W4393041131

02

Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial

Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R

Nature Medicine20227 citations

DOI: 10.1038/s41591-021-01667-1

03

Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19

Bégin P, Callum J, Cook R, Jamula E, Liu Y, Finzi A, Arnold DM

Nature Medicine20221 citations

DOI: 10.1038/s41591-021-01639-5

04

Freeze-dried plasma for major trauma - Systematic review and meta-analysis.

Mok G, Hoang R, Khan MW, Pannell D, Peng H, Tien H, Nathens A, Callum J, Karkouti K, Beckett A, da Luz LT

The journal of trauma and acute care surgery2021

DOI: 10.1097/ta.0000000000003012 PMID: 33507025

05

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial

Bégin P, Callum J, Jamula E, Cook R, Heddle NM, Tinmouth A, Zeller MP, Beaudoin-Bussières G, Amorim L, Bazin R

Nature Medicine2021261 citationsOpen Access

DOI: 10.1038/s41591-021-01488-2 PMID: W3197328793

06

Age of Transfused Blood in Critically Ill Adults

Tinmouth A, Clayton L, Blajchman MA, Capellier G, Bardiaux L, van de Watering L, Vo D, Hébert PC, Fergusson DA, Cook DJ

New England Journal of Medicine2015552 citations

DOI: 10.1056/nejmoa1500704

The ICONIC trial: Intraoperative Cell salvage to Optimize allogeNeic transfusion In liver Cancer surgery

Co-investigatorCIHR2026Project Grant

Principal investigators: Martel, Guillaume; Karanicolas, Paul J; Taljaard, Monica

Keywords: Blood Salvage; Blood Transfusion; Cell Salvage; Cholangiocarcinoma; Colorectal Cancer; Hepatectomy; Hepatocellular Carcinoma; Liver Surgery; Patient Blood Management; Survival

$1,640,542

The TOPGUN trial: Threshold for OPerative hemoGlobin trigger for red blood cell transfUsioN

Co-investigatorCIHR2026Project Grant

Principal investigators: Martel, Guillaume; Breau, Rodney H; Carrier, François M; McGinn, Ryan N; McIsaac, Daniel I; Taljaard, Monica; Turgeon, Alexis F; Verret, Michael

Keywords: Anesthesiology; Blood Transfusion; Cancer Outcomes; Perioperative Care; Perioperative Complications; Surgery

$4,039,200

Small-Volume Tubes to Reduce Anemia and Transfusion Expansion Phase (STRATUS-X) Trial Planning Grant

Co-investigatorCIHR2025Planning and Dissemination Grants - Institute/Initiative Community Support

Principal investigators: Siegal, Deborah M; Belley-Côté, Emilie Prudence

Keywords: Anemia; Cardiovascular; Hospitalization; Pragmatic Trial; Transfusion

$20,000

ALbumin To Enhance Recovery after severe Acute Kidney Injury (ALTER-AKI): a multicentre randomized controlled trial.

Principal investigatorCIHR2023Project Grant

Principal investigators: Clark, Edward G; Bagshaw, Sean M; Callum, Jeannie L; Wald, Ron

Keywords: Acute Kidney Injury; Critical Illness; Dialysis; Hemodynamic Instability Related To Renal Replacement Therapy; Intradialytic Hypotension; Intravenous Albumin; Multicentre Randomized Controlled Trial; Renal Replacement Therapy; Ultrafiltration

$956,249

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Medicine
Health Research Methods, Evidence, and Impact
Anesthesiology and Pain Management
Pathology and Molecular Medicine
Statistics and Actuarial Science
Family Medicine
Computing and Software
Other

Applying for

Paper to mentionMention their CIHR grant from 2023

Subject: Prospective PhD student: Acute Kidney Injury Dear Professor Callum, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Quality of life and cost‐effectiveness of convalescent plasma compared to standard care for hospitalized COVID‐19 patients in the CONCOR‐1 trial" (2024), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "ALbumin To Enhance Recovery after severe Acute Kidney Injury (ALTER-AKI): a multicentre randomized controlled trial." (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]